Opens in a new tab

Access

Clearing the path from product development to country availability

We help vaccines reach the people who need them most, especially in low and middle-income countries. Our work spans the full access pathway, from early product development to implementation readiness.

Value & Investment Case

We develop investment cases that link demand projections, delivery feasibility, and financing to show whether and how a product should be taken forward.

Market Readiness

We assess demand and supply dynamics, define end-to-end use cases, and support regulatory and procurement pathway planning.

Pathway Design and
Readiness Planning

We design early access pilots, launch strategies, and practical plans that align financing, policy, and operational elements to move products from pipeline to availability.

Stakeholder Engagement

We map and engage the full ecosystem from product developers to procurers to national programs to align incentives and build momentum.

We ensure that life-saving vaccines move beyond the pipeline and reach the people who need them most.

Stories of progress and partnership

Case studies that highlight solutions shaped by expertise and teamwork.

Accelerating access through strategic investment cases

READ CASE STUDY

Sustaining Vaccine Access Through Market Information for Access (MI4A)

READ CASE STUDY

Contact the MMGH Team

To find out how we can assist with your upcoming projects, please fill in this form and someone from our team will contact you shortly.

Headquarters

MMGH Consulting GmbH Kuerbergstrasse 1 8049 Zurich, Switzerland

+41 44 553 04 53

Branch

MMGH Consulting GmbH Chemin Maurice-Ravel 11C 1290 Versoix, Switzerland

+41 22 596 78 60